A phase II evaluation of tamoxifen, premarin, methotrexate (MTX) and 5-fluorouracil (5-FU) in stage IV breast cancer

J. C. Allegra, T. M. Woodcock, Stephen P Richman

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations
Original languageEnglish
Title of host publicationProceedings of the American Association for Cancer Research
VolumeVol. 22
Publication statusPublished - Jan 1 1981
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Allegra, J. C., Woodcock, T. M., & Richman, S. P. (1981). A phase II evaluation of tamoxifen, premarin, methotrexate (MTX) and 5-fluorouracil (5-FU) in stage IV breast cancer. In Proceedings of the American Association for Cancer Research (Vol. Vol. 22)